https://www.lezdotechmed.com/blog/mass-tort/invokana-lawsuits-update/
The Invokana lawsuits are one of the most recent pharma litigations in the United States. Diabetes affected approximately 37.3 million Americans, or one out of every ten people. One in every five people with diabetes were unaware of their condition. Invokana®, like all medications, had some side effects. However, when the side effects outweighed the benefits, patients began filing Invokana lawsuits.
You may already be aware that chronic diabetic patients are at risk of amputation. However, if such a diabetic medication results in amputation, this is a major cause for concern. That's exactly what happened with Invokana®. Invokana® is the brand name for canagliflozin. After metformin has been tried, it is used as a third-line medication to treat type 2 diabetes in adults. Invokana® lowers blood sugar levels and reduces the risk of cardiovascular problems, as well as preventing death.
Janssen Pharmaceuticals, Inc. marketed Invokana®, which received FDA approval as the first SGLT2 inhibitor on March 29, 2013, to be used as a supplement to diet and exercise to improve glycemic control in people with type 2 diabetes mellitus.
Physicians were instructed by the FDA to look for the following conditions in their patients before prescribing the drug. Among the risk factors are a history of prior amputation, peripheral vascular disease, neuropathy, and diabetic foot ulcers.
Yeast infections in the penis, vaginal and urinary tracts, constipation, nausea, and vomiting are the most common side effects. However, it may have some negative side effects, as listed below. Weight loss, bone fractures, dehydration, hypoglycemia, lower limb amputation, diabetic ketoacidosis, Fournier's gangrene, kidney damage, loss of balance, and allergic reactions are all possible complications.
The first class action lawsuit on Invokana was filed in in Canada. Janssen was subjected to numerous Invokana lawsuits throughout the United States. Despite the fact that New Jersey and California have received a significant number of Invokana lawsuits, Pennsylvania has received the most as a single state. After the parties reached an agreement, a significant portion of the 1,000 Invokana claims brought against Johnson Johnson alias Janssen in the New Jersey Invokana MDL No. 2750 were resolved confidentially in October 2018. However, as of September 2019, there were 878 active Invokana litigations in the New Jersey MDL.
The following were alleged in the lawsuits: 1) The risks of Invokana were not adequately communicated. 2) The risks and benefits of Invokana were misrepresented in product advertising. 3). A defective and unreasonably dangerous product was negligently manufactured and marketed. 4). As a result of this medication, patients are at risk of amputation, kidney damage, and ketoacidosis, and Janssen Pharmaceutical failed to warn consumers about these known risks. 5). Invokana was not thoroughly tested for all potential side effects by Janssen. 6). The company also had in-house FDA and consumer data indicating the drug's dangers.
Gather all of your medical records, including proof of medication start date and symptoms progression. Even if you have a large number of medical records, a medical records review company can sift through them to find important information. LezDo techmed has an expert team to assist mass tort attorneys with medical record reviews. Past and future medical expenses, punitive damages, emotional distress, wrongful death damages, and loss of consortium can all be claimed as damages.
